Home - Products - Others - Other Targets - 3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid

3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid

CAS No. 300816-42-6

3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid ( —— )

Catalog No. M28390 CAS No. 300816-42-6

3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid is a compound used as a molecular building block.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG 642 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid is a compound used as a molecular building block.
  • Description
    3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid is a compound used as a molecular building block.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    300816-42-6
  • Formula Weight
    308.2
  • Molecular Formula
    C15H11Cl2NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CCn1c2ccc(Cl)cc2c2cc(Cl)ccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Junichi Narita, et al. Freshness-keeping film. WO2014142218A1.
molnova catalog
related products
  • Etifoxine hydrochlor...

    Etifoxine is an anxiolytic and anticonvulsant drug.?Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.

  • C75

    C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM).

  • SR11237

    SR11237 is a Pan retinoid X receptor (RXR) agonist. SR11237 causes RXR/RXR homodimers to form and transactivate a reporter gene containing a RXR-response element.